Regulation of mouse κ opioid receptor gene expression by different 3′-untranslated regions and the effect of retinoic acid

Molecular Pharmacology

Volumn 62, Issue 4, 2002, Pages 881-887

  Hu, Xinli ^a   Bi, Jing ^a   Loh, Horace H ^a   Wei, Li Na ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KAPPA OPIATE RECEPTOR; LUCIFERASE; MESSENGER RNA; POLYADENYLIC ACID; RETINOIC ACID;

3' UNTRANSLATED REGION; ALTERNATIVE RNA SPLICING; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENHANCER REGION; GENE EXPRESSION REGULATION; MOUSE; NONHUMAN; NORTHERN BLOTTING; POLYADENYLATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA STABILITY; TRANSCRIPTION REGULATION;

3' UNTRANSLATED REGIONS; ANIMALS; ANTINEOPLASTIC AGENTS; BASE SEQUENCE; GENE EXPRESSION REGULATION; MICE; MOLECULAR SEQUENCE DATA; RECEPTORS, OPIOID, KAPPA; RNA STABILITY; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRANSFECTION; TRETINOIN;

EID: 0036783691     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.62.4.881     Document Type: Article

References (23)

1. Belkowski SM, Zhu J, Liu-Chen LY, Eisenstein TK, Adler MW, and Rogers TJ (1995) Sequence of k-opioid receptor cDNA in the R1.1 thymoma cell line. J Neuroimmunol 62:113-117.
2. Bentley D (1999) Coupling RNA polymerase II transcription with pre-mRNA processing. Curr Opin Cell Biol 11:347-351.
3. Bi J, Hu X, Loh HH, and Wei LN (2001) Regulation of mouse k opioid receptor gene expression by retinoids. J Neurosci 21:1590-1599.
4. Dantonel JC, Murthy KG, Manley JL, and Tora L (1997) Transcription factor TFIID recruits factor CPSF for formation of 3′ end of mRNA. Nature (Lond) 389:399-402.
5. Edwalds-Gilbert G, Prescott J, and Falck-Pedersen E (1993) 3′ RNA processing efficiency plays a primary role in generating termination-competent RNA polymerase II elongation complexes. Mol Cell Biol 13:3472-3480.
6. Edwalds-Gilbert G, Veraldi KL, and Milcarek C (1997) Alternative poly(A) site selection in complex transcription units: means to an end. Nucleic Acids Res 25:2547-2561.
7. Gaveriaux-Ruff C, Peluso J, Befort K, Simonin F, Zilliox C, and Kieffer BB (1997) Detection of opioid receptor mRNA by RT-PCR reveals alternative splicing for the δ- and κ-opioid receptors. Mol Brain Res 48:298-304.
8. Goldstein A and Naidu A (1989) Multiple opioid receptors: ligand selectivity profiles and binding site signatures. Mol Pharmacol 36:265-272.
9. Hirose Y and Manley JL (1998) RNA polymerase II is an essential mRNA polyadenylation factor. Nature (Lond) 395:93-96.
10. Hu XL, Bi J, Loh HH, and Wei LN (2001) An intronic Ikaros-binding element mediates retinoic acid suppression of the kappa opioid receptor gene, accompanied by histone deacetylation on the promoter. J Biol Chem 276:4597-4603.
11. Liu HC, Lu S, Augustin LB, Felsheim RF, Chen HC, Loh HH, and Wei LN (1995) Cloning and promoter mapping of mouse kappa opioid receptor gene. Biochem Biophys Res Commun 209:639-647, 1995.
12. Lu SL, Loh HH, and Wei LN (1997) Studies of dual promoters of mouse κ-opioid receptor gene. Mol Pharmacol 52:415-420.
13. Masabumi M and Satoh M (1995) Molecular biology of the opioid receptors: structures, functions and distributions. Neurosci Res 23:121-145.
14. McCracken S, Fong N, Yankulov K, Ballantyne S, Pan GH, Greenblatt J, Patterson SD, Wickens M, and Bentley DL (1997) The C-terminal domain of RNA polymerase II couples messenger RNA processing to transcription. Nature (Lond) 385:357-361.
15. Minvielle-Sebastiz L and Keller W (1999) mRNA polyadenylation and its coupling to other RNA processing reactions and to transcription. Curr Opin Cell Biol 11:352-357.
16. Pan YX, Xu A, Mahurter L, Bolan E, Xu MM, and Pasternak GW (2001) Generation of the mu opioid receptor (MOR-1) protein by three new splice variants of the Oprm gene. Proc Natl Acad Sci USA 98:14084-14089.
17. Pan YX, Xu J, Bolan E, Abbadie, Chang A, Zuckerman A, Rossi G, and Pasternak GW (1999) Identification and characterization of three new alternatively spliced mu-opioid receptor isoforms. Mol Pharmacol 56:396-403.
18. Sambrook J and Russell DW (2001) Transcriptional run-on assay, in Molecular Cloning: A Laboratory Manual, 3rd ed, pp 17.23-17.29, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
19. Sheets MD, Ogg SC, and Wickens MP (1990) Point mutations in AAUAAA and the poly(A) addition site: effects on the accuracy and efficiency of cleavage and polyadenylation in vitro. Nucleic Acids Res 18:5799-5805.
20. Wei LN and Loh HH (1996) Molecular biology of opioid receptors and associate proteins, in Handbook of Psychiatric Genetics (Blum K and Noble EP eds) pp 77-88. CRC, New York.
21. Wei LN and Loh HH (2002) Regulation of opioid receptor expression. Curr Opin Pharm 2:69-75.
22. Wei LN, Hu XL, Bi J, and Loh HH (2000) Post-transcriptional regulation of mouse kappa-opioid receptor expression. Mol Pharmacol 57:401-408.
23. Zhao J, Hyman L, and Moore C (1999) Formation of mRNA 3′ ends in eukaryotes: mechanism, regulation and interrelationships with other steps in mRNA synthesis. Microbiol Mol Biol Rev 63:405-445.